Osteogenic protein-1: biology and applications
- PMID: 8595770
Osteogenic protein-1: biology and applications
Abstract
Osteogenic proteins, also referred to as BMPs, are a family of bone matrix polypeptides isolated from a variety of mammalian species. These proteins are members of the transforming growth factor-beta superfamily of molecules that contain a highly conserved 7 cysteine transforming growth factor-beta domain in their C-termini. Use of recombinantly produced human osteogenic protein-1, also referred to as BMP-7, implanted in conjunction with bovine bone derived Type 1 collagen or various non-proteinaceous biodegradable carriers into surgically created large diaphyseal segmental defects in animals leads to the regeneration of new bone that is fully functional biologically and biomechanically. Further study has shown that osteogenic protein-1 can be used as a bone graft substitute to promote spinal fusion and to aid in the incorporation of metal implants. Finally, osteogenic protein-1 shows promise as an agent for repair of osteochondral defects.
Similar articles
-
Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites.Orthopedics. 1999 Jul;22(7):669-71. Orthopedics. 1999. PMID: 10418861 Review.
-
Bone morphogenetic protein-2: biology and applications.Clin Orthop Relat Res. 1996 Mar;(324):39-46. Clin Orthop Relat Res. 1996. PMID: 8595775 Review.
-
Bone morphogenetic proteins in craniofacial and periodontal tissue engineering: experimental studies in the non-human primate Papio ursinus.Cytokine Growth Factor Rev. 2005 Jun;16(3):357-68. doi: 10.1016/j.cytogfr.2005.02.006. Cytokine Growth Factor Rev. 2005. PMID: 15951219 Review.
-
Use of osteoinductive implants in the treatment of bone defects.Med Prog Technol. 1994;20(3-4):155-68. Med Prog Technol. 1994. PMID: 7877560 Review.
-
Pleiotropism of bone morphogenetic proteins: from bone induction to cementogenesis and periodontal ligament regeneration.J Int Acad Periodontol. 2006 Jan;8(1):23-32. J Int Acad Periodontol. 2006. PMID: 16459886 Review.
Cited by
-
Biologic agents in osteoarthritis: hopes and disappointments.Nat Rev Rheumatol. 2013 Jul;9(7):400-10. doi: 10.1038/nrrheum.2013.44. Epub 2013 Apr 2. Nat Rev Rheumatol. 2013. PMID: 23545735 Review.
-
How does the pathophysiological context influence delivery of bone growth factors?Adv Drug Deliv Rev. 2015 Apr;84:68-84. doi: 10.1016/j.addr.2014.10.010. Epub 2014 Oct 17. Adv Drug Deliv Rev. 2015. PMID: 25453269 Free PMC article. Review.
-
Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis.BMC Musculoskelet Disord. 2010 Oct 10;11:232. doi: 10.1186/1471-2474-11-232. BMC Musculoskelet Disord. 2010. PMID: 20932341 Free PMC article. Clinical Trial.
-
Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinities.Growth Factors. 2011 Aug;29(4):128-39. doi: 10.3109/08977194.2011.593178. Epub 2011 Jun 27. Growth Factors. 2011. PMID: 21702718 Free PMC article.
-
A novel ex vivo model for investigation of fluid displacements in bone after endoprosthesis implantation.J Mater Sci Mater Med. 1999 Dec;10(12):801-6. doi: 10.1023/a:1008919521056. J Mater Sci Mater Med. 1999. PMID: 15347955
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials